INSULET CORP Development Agreements
4 Contracts & Agreements
- Amendment No. 1 to the Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care, Inc., dated January 5, 2022 (Filed With SEC on February 23, 2024)
- Amended and Restated Development and Commercialization Agreement by and between Insulet Corporation and Abbott Diabetes Care, Inc., dated September 13, 2021 (Filed With SEC on February 23, 2024)
- Amendment No.1 to Development Agreement by and between Insulet Corporation and DexCom, Inc, dated November 21, 2019 (Filed With SEC on August 5, 2022)
- Development Agreement by and between Insulet Corporation and DexCom, Inc, dated December 7, 2016 (Filed With SEC on August 5, 2022)